[HTML] nature.comFull View

[HTML][HTML] Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

C Usai, E Ainsua-Enrich, VU Gales, E Pradenas… - npj Vaccines, 2024 - nature.com
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 …
相关文章

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.

C Usai, E Ainsua-Enrich, VU Gales, E Pradenas… - NPJ …, 2024 - europepmc.org
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 …

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

C Usai, E Ainsua-Enrich, VU Gales… - NPJ …, 2024 - pubmed.ncbi.nlm.nih.gov
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 …
[HTML] nih.gov

[HTML][HTML] Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models

C Usai, E Ainsua-Enrich, VU Gales, E Pradenas… - NPJ …, 2024 - ncbi.nlm.nih.gov
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 …

Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models.

C Usai, E Ainsua-Enrich, VU Gales, E Pradenas… - NPJ …, 2024 - europepmc.org
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 …